JPM KRAS G12C deep dive ahead of #ASCO20

- Data comparison of $AMGN sotorasib (AMG 510) vs $MRTX MRTX849
- Other key players in clinical development: $JNJ / Wellspring, $LLY &amp; Boehringer Ingelheim
- Estimated TAM ceiling of $5.5B in KRAS G12C+ #NSCLC https://t.co/yeQzvcJ1Xe